Good news! Cancer is history! This is only the beginning of advances in cancer immunotherapy!
"Immunomedics is stopping a Phase 3 clinical trial due to “compelling evidence of efficacy” demonstrated in patients with advanced, triple-negative breast cancer ... The decision to halt the study involving the Immunomedics drug called sacituzumab govitecan ... "
Immunomedics halts late-stage trial, confirming breast cancer drug benefit: The positive outcome could help reverse the pessimism about the breast cancer drug that has weighed heavily on Immunomedics.
No comments:
Post a Comment